Added to Your Shopping Cart
Certificate of Analysis
Are you looking for...
You might be interested in...
Type in Product name, Keyword or Catalog number to see suggestions.
Looking for a Certificate of Analysis?
Have your catalog and lot numbers ready and click the link.
Find CoA
Need help? Please contact us
You searched for "natural killer cells"
Too many choices? Use the filter option on the left to narrow your product listing.
-
NK – Human Natural Killer CellsCatalog #: 2W-502Human Natural Killer Cells pos selection, ≥5 million cellsSales unit: each
-
Human Natural Killer Cell Nucleofector® KitCatalog #: VPA-1005
For efficient transfection of primary NK (natural killer) cells in the Nucleofector® I/II/2b System
Sales unit: items -
NK - Human Natural Killer Cells, Cryopreserved, Negative Selection, 5 MillionCatalog #: 2W-501
Crypreserved ampule of Peripheral Blood Human Natural Killer Cells (CD56 negative immunomagnetic selection) containing ≥ 5 million cells
Sales unit: each -
TheraPEAK™ X-VIVO™-10 Serum-free Hematopoietic Cell MediumCatalog #: BEBP02-055Q
TheraPEAK™X-VIVO™ 10, Serum free hematopoietic cell medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 1 L
Sales unit: each -
TheraPEAK™ X-VIVO™-10 Serum-free Hematopoietic Cell MediumCatalog #: BP04-743QTheraPEAK™X-VIVO™ 10, Serum free hematopoietic cell medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 1 LSales unit: Bottle
-
X-VIVOTM 15 Serum-free Hematopoietic Cell MediumCatalog #: 02-060QX-VIVO™ 15, Serum-free hematopoietic cell medium, with L-Glutamine, gentamicin and phenol red, xenofree, 1 LSales unit: each
-
TheraPEAK™ X-VIVO™-15 Serum-free Hematopoietic Cell MediumCatalog #: 08-879HTheraPEAK™X-VIVO™ 15, Serum-free hematopoietic cell medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 5L bagSales unit: Bag
-
TheraPEAKTM X-VIVOTM 15 Serum-free Hematopoietic Cell Medium with recombinant transferrinCatalog #: BEBP02-054Q
TheraPEAKTMX-VIVOTM 15, Serum-free hematopoietic cell medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 1 L
Sales unit: each -
TheraPEAKTM X-VIVOTM 15 Serum-free Hematopoietic Cell MediumCatalog #: BE08-879P1TheraPEAK™X-VIVO™ 15, Serum-free hematopoietic cell medium, with L-Glutamine, without gentamicin and phenol red, xenofree, 1L bagSales unit: each
-
TheraPEAK™ X-VIVO™-15 Serum-free Hematopoietic Cell Medium with recombinant transferrinCatalog #: BEBP02-054P1TheraPEAK™X-VIVO™ 15, Serum-free hematopoietic cell medium, with recombinant transferrin,and L-Glutamine, without gentamicin and phenol red, xenofree, 1L bagSales unit: each
Added to Your Shopping Cart
-
Natural Killer Cells InfographicNatural Killer cells have an innate ability to recognize and destroy non-self cells.
-
3D Natural Killer Cell-mediated Cytotoxicity AssayLonza White Paper
-
3D Natural Killer (NK) Cell-mediated Cytotoxicity (CMC) Assay
-
Natural Killer (NK) Cell Expansion, Activation and Cytotoxicity AssayProtocol instructions
-
Therapeutic Approaches to Enhance Natural Killer Cell Cytotoxicity: The Force AwakensPoster published by Nature Reviews Drug Discovery, sponsored by Lonza. Natural killer (NK) cells are emerging as attractive candidates for new immunotherapeutic approaches. The poster shows the approaches to NK cell tumor targeting.
-
Transfection Protocol for Human NK Cells - Nucleofector™ I/II/2b Device SeriesInstructions of use for transfection of human natural killer cells with Nucleofector™ 1/2 Devices (incl. 1, 2b, 2N, 2S)
-
An Innovative, Highly Efficient Method for Transfecting Large Quantities of Primary Human T-cellsA strong need exists for improved cancer treatment options. Lonza's approach relies on genetically modified, patient-derived cells like T-cells or natural killer cells which express chimeric antigen receptors (CAR) targeting cancer cells.
-
NK Cell Assay using 3D Bioprinted Tumor ModelsThis white paper describes an ex vivo assay for NK cell killing activity in a 3D bioprinted cervical cancer tumor model.
-
TechSheet - Poietics™ Human Immune System CellsTechnical Product Information Sheet
-
CAR T cells in Cancer TherapyA poster developed by Nature Reviews in conjunction with Lonza to present CAR T cells in cancer therapy. This poster demonstrates the recognition of tumor peptides by T cells, CAR T cell manufacturing, the types of chimeric antigen receptors and a timeline of CAR development over more than 30 years.
Product Availability by Store Location
Hours